August 24, 2018
Dr. Reddy's Laboratories Inc. is recalling 2280 bottles of atorvastatin calcium tablets, 40 mg, because samples failed to meet impurity and degradation specifications, according to the August 22, 2018, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects 500-count bottles (NDC 55111-123-05) from lot T60045. The affected bottles were distributed across the United States.
Dr. Reddy's Laboratories Inc. voluntarily initiated the recall August 2, 2018. On August 14, 2018, the FDA designated the recall Class III, suggesting use of the drug is not likely to cause an adverse health reaction.
Atorvastatin calcium tablets are prescription statins that help lower low-density lipoprotein (LDL) and triglycerides in the blood and raise levels of high-density lipoprotein (HDL).
For more Pharmacy Learning Network articles, visit the homepage
To learn about Pharmacy Learning Network Live meetings, click here